載入...

Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes

OBJECTIVE: Interleukin (IL)-1 impairs insulin secretion and induces β-cell apoptosis. Pancreatic β-cell IL-1 expression is increased and interleukin-1 receptor antagonist (IL-1Ra) expression reduced in patients with type 2 diabetes. Treatment with recombinant IL-1Ra improves glycemia and β-cell func...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Larsen, Claus M., Faulenbach, Mirjam, Vaag, Allan, Ehses, Jan A., Donath, Marc Y., Mandrup-Poulsen, Thomas
格式: Artigo
語言:Inglês
出版: American Diabetes Association 2009
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2732140/
https://ncbi.nlm.nih.gov/pubmed/19542207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-0533
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!